On november 21st, Head of preclinical research Dr. Sandro Alves presented Brainvectis as an example of spin-off translating academic preclinical research into industrial development.
NeurATRIS is a research infrastructure conceived to accelerate the translation of discoveries in basic research into medical innovations for the treatment of diseases of the nervous system.